'Eye Stroke' Warning For Ozempic Users: What Is NAION And How Dangerous Is It? | Vantage

The US Food and Drug Administration has told weight loss drugmakers like Novo Nordisk and Eli Lilly to put new warning labels on their weight loss and diabetes drugs like Ozempic, Wegovy, Mounjaro and Zepbound, informing customers of the higher risk of non-arteritic anterior ischemic optic neuropathy (NAION), or "eye strokes". The US FDA has conducted 126 clinical trials and found that GLP-1 RA weight loss drugs increase the risk of NAION in patients. Firstpost explains what NAION eye strokes…